# OnCo record fcrh5-expression (biomarker). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/biomarkers/fcrh5-expression/>
  a schema:MedicalTest ;
  onco:kind "biomarker" ;
  schema:identifier "fcrh5-expression" ;
  schema:name "FcRH5 expression"@en ;
  schema:alternateName "FcRH5"@en, "FCRL5 expression"@en, "FcRH5-positive"@en ;
  schema:description "FcRH5 is a third myeloma surface target after BCMA and GPRC5D. Cevostamab, the FcRH5 x CD3 bispecific, is in phase 3; no approval or threshold exists yet."@en ;
  schema:url <https://onco.cc/biomarkers/fcrh5-expression/> ;
  schema:dateModified "2026-09-23"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05535244> ;
  onco:tag "biomarker", "surface-antigen", "no-threshold" ;
  onco:related <https://onco.cc/biomarkers/bcma-expression/>, <https://onco.cc/biomarkers/gprc5d-expression/> ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/>, <https://onco.cc/cancers/myeloma-relapsed-refractory/> ;
  onco:drugs <https://onco.cc/drugs/cevostamab/> .